Effect of recombinant human prourokinase on thrombolysis in a rabbit model of thromboembolic stroke

Furlan, 1999, Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial. Prolyse in acute cerebral thromboembolism, JAMA, 282, 2003, 10.1001/jama.282.21.2003

Gurewich, 1984, Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species, J Clin Invest, 73, 1731, 10.1172/JCI111381

del Zoppo, 1998, PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT investigators. Prolyse in acute cerebral thromboembolism, Stroke, 29, 4, 10.1161/01.STR.29.1.4

Moia, 1994, A pilot study of pro-urokinase in the treatment of deep vein thrombosis, Thromb Haemost, 72, 430, 10.1055/s-0038-1648884

Ning, 2008, A new thrombolytic drug: Recombinant human prourokinase, Zhongguo Xin Yao Zazhi, 17, 430

Liu, 2015, Efficacy and safety of thrombolytic therapy with recombinant human prourokinase for acute myocardial infarction in 50 cases, Chin Pharm J, 15, 76

Thomas, 1993, Optimized thrombolysis of cerebral clots with tissue-type plasminogen activator in a rabbit model of embolic stroke, J Pharmacol Exp Ther, 264, 67

Hao, 2017, Application of 99Tcm tracer technique in rabbit cerebral thromboembolic stroke, Yaowu Pingjia Yanjiu, 40, 648

Zhang, 2015, Focal embolic cerebral ischemia in the rat, Nat Protoc, 10, 539, 10.1038/nprot.2015.036

Feng, 2013, Establishing a model of middle cerebral artery occlusion in rabbits using endovascular interventional techniques, Exp Ther Med, 6, 947, 10.3892/etm.2013.1248

Zhang, 1997, A new rat model of thrombotic focal cerebral ischemia, J Cereb Blood Flow Metab, 17, 123, 10.1097/00004647-199710000-00010

Yu, 2005, Thrombolytic efficacy of rt-PA in embolic stroke of rabbits by 99Tcm trace, J Isot, 18, 160

Thomas, 1994, A long-half-life and fibrin-specific form of tissue plasminogen activator in rabbit models of embolic stroke and peripheral bleeding, Stroke, 25, 2072, 10.1161/01.STR.25.10.2072

Bovill, 1991, Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI), Phase II trial, Ann Intern Med, 115, 256, 10.7326/0003-4819-115-4-256

Clark, 1991, Cerebral hemorrhagic risk of aspirin or heparin therapy with thrombolytic treatment in rabbits, Stroke, 22, 872–876, 10.1161/01.STR.22.7.872

Chapman, 2001, Comparison of TNK with wild-type tissue plasminogen activator in a rabbit embolic stroke model, Stroke, 32, 748, 10.1161/01.STR.32.3.748

Mozaffarian, 2015, Heart disease and stroke statistics-2015 update: A report from the American heart association, Circulation, 131, 29, 10.1161/CIR.0000000000000157

Amar, 2015, Combined neurothrombectomy or thrombolysis with adjunctive delivery of 3K3A-activated protein C in acute ischemic stroke, Front Cell Neurosci, 9, 344, 10.3389/fncel.2015.00344

So, 2013, Breaking news: The ‘biggest, baddest’ controversy in EM, Emerg Med News, 35, 26

Furlan, 2002, The role of recombinant pro-urokinase (r-pro-UK) and intra-arterial thrombolysis in acute ischaemic stroke: The PROACT trials. Prolyse in acute cerebral thromboembolism, Curr Med Res Opin, 18, 44, 10.1185/030079902125000723

Prourokinase Clinical Trial Group, 2013, Multicenter phase III study of recombinant prourokinase for acute myocardial infarction with ST-segment evaluation, J Med Res, 42, 26

Tirschwell, 2001, Intra-arterial urokinase for acute ischemic stroke: Factors associated with complications, Neurology, 57, 1100, 10.1212/WNL.57.6.1100

Zhang, 2011, Investigation of pharmacodynamics, pharmacology, and toxicology of domestic human prourokinase, Sci Sin Vitae, 41, 1024, 10.1360/052011-593